Literature DB >> 29084500

The impact of venovenous extracorporeal membrane oxygenation on cytokine levels in patients with severe acute respiratory distress syndrome: a prospective, observational study.

A J C Burrell1, M Lubnow2, T B Enger3, V B Nanjayya4, A Philipp5, M V Malfertheiner2, D Lunz3, T Bein5, V A Pellegrino6, T Müller2.   

Abstract

OBJECTIVE: The immunoinflammatory response is central to the pathogenesis of acute respiratory distress syndrome (ARDS). However, little is known how this is affected by venovenous (VV) extracorporeal membrane oxygenation (ECMO). Our objective was to investigate the factors that influence the inflammatory response of patients with ARDS undergoing VV ECMO, and to analyse the impact of this response on hospital mortality. DESIGN AND
SETTING: A prospective observational study of all consecutive patients with severe ARDS who had VV ECMO at a tertiary German ECMO centre from 2009 to 2015. Patients without complete datasets were excluded. Cytokines (interleukin [IL]6, IL8 and tissue necrosis factor [TNF]α) and inflammatory markers (white cell count and C-reactive protein) were assessed before ECMO initiation and on Days 1, 5 and 10, before explantation and at explantation.
RESULTS: A total of 262 adult patients undergoing VV ECMO were analysed. Their median Sequential Organ Failure Assessment score was 12, PaO2/FiO2 ratio was 64 mmHg, and overall in-hospital mortality was 34%. Cytokine levels fell quickly within 24 hours and fell further over the first 5 days. Extra-pulmonary ARDS was associated with higher IL6 and IL8 levels compared with pulmonary ARDS. Mechanical ventilation with positive end-expiratory pressure ≥ 15 cmH2O before ECMO was associated with higher IL6, IL8 and TNFα levels. Driving pressures ≥ 19 cmH2O before ECMO were associated with higher IL8 levels. Non-survivors had higher IL6 and IL8 levels for the duration of ECMO.
CONCLUSION: Cytokine levels, on average, fall rapidly after initiation of VV ECMO, which may be related to the reduction of invasiveness of mechanical ventilation. Higher cytokine levels are associated with extrapulmonary causes of ARDS, more aggressive mechanical ventilation before VV ECMO, and mortality.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29084500

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  7 in total

1.  Inflammation in venovenous extracorporeal membrane oxygenation: villain or innocent bystander?

Authors:  Aidan Burrell; Thomas Müller
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  What about prognostic outcome parameters in patients with acute respiratory distress syndrome (ARDS) treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO)?

Authors:  Thomas Datzmann; Karl Träger
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  ARDS Clinical Practice Guideline 2021.

Authors:  Sadatomo Tasaka; Shinichiro Ohshimo; Muneyuki Takeuchi; Hideto Yasuda; Kazuya Ichikado; Kenji Tsushima; Moritoki Egi; Satoru Hashimoto; Nobuaki Shime; Osamu Saito; Shotaro Matsumoto; Eishu Nango; Yohei Okada; Kenichiro Hayashi; Masaaki Sakuraya; Mikio Nakajima; Satoshi Okamori; Shinya Miura; Tatsuma Fukuda; Tadashi Ishihara; Tetsuro Kamo; Tomoaki Yatabe; Yasuhiro Norisue; Yoshitaka Aoki; Yusuke Iizuka; Yutaka Kondo; Chihiro Narita; Daisuke Kawakami; Hiromu Okano; Jun Takeshita; Keisuke Anan; Satoru Robert Okazaki; Shunsuke Taito; Takuya Hayashi; Takuya Mayumi; Takero Terayama; Yoshifumi Kubota; Yoshinobu Abe; Yudai Iwasaki; Yuki Kishihara; Jun Kataoka; Tetsuro Nishimura; Hiroshi Yonekura; Koichi Ando; Takuo Yoshida; Tomoyuki Masuyama; Masamitsu Sanui
Journal:  J Intensive Care       Date:  2022-07-08

Review 4.  ECLS-associated infections in adults: what we know and what we don't yet know.

Authors:  Darryl Abrams; Giacomo Grasselli; Matthieu Schmidt; Thomas Mueller; Daniel Brodie
Journal:  Intensive Care Med       Date:  2019-11-25       Impact factor: 41.787

5.  The relationship between antithrombin administration and inflammation during veno-venous ECMO.

Authors:  Mauro Panigada; Elena Spinelli; Stefano De Falco; Dario Consonni; Cristina Novembrino; Massimo Boscolo Anzoletti; Giovanna Panarello; Giovanna Occhipinti; Claudia C Dos Santos; Antonio Pesenti; Antonio Arcadipane; Giacomo Grasselli
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

Review 6.  Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Authors:  Xiaochun Ma; Menglin Liang; Min Ding; Weiming Liu; Huibo Ma; Xiaoming Zhou; Hongsheng Ren
Journal:  Med Sci Monit       Date:  2020-08-06

Review 7.  A rational approach on the use of extracorporeal membrane oxygenation in severe hypoxemia: advanced technology is not a panacea.

Authors:  Dimitris Georgopoulos; Laurent Brochard; Evangelia Akoumianaki; Annemijn Jonkman; Michael C Sklar
Journal:  Ann Intensive Care       Date:  2021-07-12       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.